Jan 29, 2015 at 10:33 | Source: CNBC-TV18
Jignesh Shial, Banking Anlayst, IDBI Capital, says approval of equity dilution in HDFC Bank would help boost credit growth and the stock is a buy at current juncture.
Jan 28, 2015 at 11:22 | Source: Moneycontrol.com
Macquarie maintains outperform rating on the stock with an increased target price of Rs 4500 (from Rs 3650) per share. It has also raised FY15-17 EPS by 1-6 percent on better margin outlook and hopes that Maruti is best placed to benefit from the cyclical upturn in auto demand in India.
Jan 27, 2015 at 14:19 | Source: CNBC-TV18
The US FDAs decision to revoke the 180-day exclusivity cover extended to Indian firm Ranbaxy to sell a generic version of the worlds second-largest selling drug esomeprazole is likely to help rival Cipla, according to Vivek Kumar, research analyst, SBICap Securities.
Jan 15, 2015 at 18:52 | Source: Moneycontrol.com
A CNBC-TV18 poll of analysts forecasts Wipros dollar revenues to grow 0.76 percent to USD 1785 million while revenue in rupee terms may rise 1.35 percent to Rs 11,070 crore. Operating profits are seen at Rs 2,431 crore while EBIT margin is seen unchanged at 22 percent.
Jan 09, 2015 at 13:07 | Source: Moneycontrol.com
In what could act as a further flashpoint for equities that appear to have run into nervousness of late, most analysts have muted expectations from the set of third-quarter earnings India Inc will start reporting from tomorrow.
Jan 06, 2015 at 15:25 | Source: CNBC-TV18
FMCG major Godrej Consumer Products Ltd (GCPL) today said it has fully acquired South Africa's hair extensions firm Frika Hair (Pty) for an undisclosed sum in order to consolidate its position in the South African market.
Jan 05, 2015 at 16:04 | Source: CNBC-TV18
Basudeb Banerjee of Antique Stock Broking is bullish on Maruti citing a strong launch pipeline in the coming 24 months. The house is also upbeat on Ashok Leyland with recovery in commercial vehicle segment.
Jan 05, 2015 at 14:15 | Source: Moneycontrol.com
Cadila's price hike of HydroxyChloroquine (antimalarial drug) after IPCA and Ranbaxy exit will add 15 percent to FY16 EPS. The benefit of higher prices and market share is likely to reflect in December 14 quarter results, it adds.
Dec 29, 2014 at 18:43 | Source: Moneycontrol.com
ICICIdirect.com has come out with its market strategy report for 2015. "Factoring in the fall in inflation, comfortable CAD, improved sentiments and pick-up in GDP growth, we expect the Sensex EPS to grow at a CAGR of 17% over FY14-17E", says the research firm.
Dec 23, 2014 at 15:26 | Source: CNBC-TV18
Essel Propack received approval to merge EP Lamitubes with Essel Propack and their respective shareholders from the Bombay High Court. Ashok Goel, VC & MD, Essel Propack told CNBC-TV18 that the merger will cut administrative cost related to overseas investments and the company is also planning to undertake more restructuring.